# 673rd Medical Group (Department of Defense - Air Force) – FDA Inspection, Mar 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/673rd-medical-group-department-of-defense-air-force/518f553f-106f-426a-ae56-cc07e934c7b0
Source feed: FDA_Inspections

> FDA inspection 1006804 of 673rd Medical Group (Department of Defense - Air Force), March 21, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006804
- Company Name: 673rd Medical Group (Department of Defense - Air Force)
- Inspection Date: 2017-03-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1253765 - 2024-11-06
- FDA Inspection 1091718 - 2019-05-07
- FDA Inspection 924236 - 2015-04-28
- FDA Inspection 829508 - 2013-04-17
- FDA Inspection 721823 - 2011-04-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-s-kessler/f3a9dea7-3a2d-4c86-9ec6-97791f9b6c21)

Company: https://www.keypedia.com/companies/673rd-medical-group-department-of-defense-air-force/365e2b52-980e-465d-ab0b-f0ea09d32731

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d